FR2474313A1 - Preparation de plasminogene et son procede de production - Google Patents

Preparation de plasminogene et son procede de production Download PDF

Info

Publication number
FR2474313A1
FR2474313A1 FR8100964A FR8100964A FR2474313A1 FR 2474313 A1 FR2474313 A1 FR 2474313A1 FR 8100964 A FR8100964 A FR 8100964A FR 8100964 A FR8100964 A FR 8100964A FR 2474313 A1 FR2474313 A1 FR 2474313A1
Authority
FR
France
Prior art keywords
plasminogen
salt
preparation
salts
metal salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8100964A
Other languages
English (en)
French (fr)
Other versions
FR2474313B1 (online.php
Inventor
Yahiro Uemura
Katsuhiro Uriyu
Satoshi Funakoshi
Ryozo Watanabe
Mitsuomi Ohgaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP807280A external-priority patent/JPS56106594A/ja
Priority claimed from JP9134180A external-priority patent/JPS5716824A/ja
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of FR2474313A1 publication Critical patent/FR2474313A1/fr
Application granted granted Critical
Publication of FR2474313B1 publication Critical patent/FR2474313B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
FR8100964A 1980-01-25 1981-01-20 Preparation de plasminogene et son procede de production Granted FR2474313A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP807280A JPS56106594A (en) 1980-01-25 1980-01-25 Stabilizing method of plasminogen
JP9134180A JPS5716824A (en) 1980-07-03 1980-07-03 Plasminogen pharmaceutical and stabilizing method thereof

Publications (2)

Publication Number Publication Date
FR2474313A1 true FR2474313A1 (fr) 1981-07-31
FR2474313B1 FR2474313B1 (online.php) 1984-02-10

Family

ID=26342511

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8100964A Granted FR2474313A1 (fr) 1980-01-25 1981-01-20 Preparation de plasminogene et son procede de production

Country Status (5)

Country Link
CH (1) CH650273A5 (online.php)
DE (1) DE3102217C2 (online.php)
FR (1) FR2474313A1 (online.php)
GB (1) GB2068002B (online.php)
SE (2) SE459783B (online.php)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0480906A3 (en) * 1990-10-11 1992-07-01 Immuno Aktiengesellschaft Pharmaceutical preparation on basis of lys-plasminogen

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119157A1 (de) * 1981-05-14 1982-12-09 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von und danach hergestelltes plasminogen
CA2007545A1 (en) * 1989-01-13 1990-07-13 Yahiro Uemura Production method for protein-containing composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066079A (en) * 1959-09-18 1962-11-27 American Cyanamid Co Methods for purifying plasminogen
FR2258393A1 (online.php) * 1974-01-11 1975-08-18 Abbott Lab

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2347048A2 (fr) * 1976-04-07 1977-11-04 Choay Sa Compositions constituees par des composes du type plasminogene, notamment d'origine placentaire, procede d'obtention des ces compositions, et medicaments contenant ces compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066079A (en) * 1959-09-18 1962-11-27 American Cyanamid Co Methods for purifying plasminogen
FR2258393A1 (online.php) * 1974-01-11 1975-08-18 Abbott Lab

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA1964 *
CA1967 *
CA1980 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0480906A3 (en) * 1990-10-11 1992-07-01 Immuno Aktiengesellschaft Pharmaceutical preparation on basis of lys-plasminogen

Also Published As

Publication number Publication date
SE8803798L (sv) 1988-10-24
GB2068002B (en) 1983-06-29
SE8100393L (sv) 1981-07-26
FR2474313B1 (online.php) 1984-02-10
DE3102217A1 (de) 1981-11-26
SE8803798D0 (sv) 1988-10-24
DE3102217C2 (de) 1987-02-12
GB2068002A (en) 1981-08-05
SE459783B (sv) 1989-08-07
CH650273A5 (de) 1985-07-15

Similar Documents

Publication Publication Date Title
Lazarus et al. Role of granulocyte collagenase in collagen degradation
EP0528701B1 (fr) Procédé de préparation d'un concentré de thrombine humaine destiné à un usage thérapeutique
Aspán et al. The effect of endogeneous proteinase inhibitors on the prophenoloxidase activating enzyme, a serine proteinase from crayfish haemocytes
Nozaki [65] Metapyrocatechase (Pseudomonas)
Pérez et al. Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine
CA1158551A (en) Plasminogen preparations
EP0547932A1 (fr) Procédé de fabrication d'un concentré de facteur VII activé de haute pureté
CA1163922A (en) Method for stabilizing plasminogen
Baum et al. Studies on sulphatases. 21. The anomalous kinetics of arylsulphatase A of human tissues: the anomalies
Markland Jr [19] Crotalase
Kress et al. Enzymatic inactivation of human serum proteinase inhibitors by snake venom proteinases
JPH0775572A (ja) ウイルスを不活性化したＸａ因子調製物
Mahler [124] Diaphorases
Tani et al. Characterization, primary structure and molecular evolution of anticoagulant protein from Agkistrodon actus venom
Hartl et al. Adenosine cyclic 3', 5'-phosphate-dependent protein kinase from bovine brain: inactivation of the catalytic subunit and holoenzyme by 7-chloro-4-nitro-2, 1, 3-benzoxadiazole
Chen et al. Retinyl esterase activity of purified rat liver retinyl ester lipoprotein complex
FR2364457A1 (fr) Procede de stabilisation d'un co-enzyme et d'un enzyme labiles
Zucker et al. Purification and characterization of a connective-tissue-degrading metalloproteinase from the cytosol of metastatic melanoma cells
Moss et al. Effects of chymotrypsin and a calcium-dependent protein activator on guanosine 3′, 5′-monophosphate phosphodiesterase from rat liver
US5945103A (en) Process for producing thrombin
JPH1052267A (ja) プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
Wilkinson et al. Complex compositional and functional diversity of venom metalloproteinases in African puff adders
Chandrasekhar et al. Fibrin clot formation and the release of carbohydrate
EP0424498B1 (fr) Procede de preparation de la proteine c activee
GB2068002A (en) Plasminogen preparations and their production

Legal Events

Date Code Title Description
ST Notification of lapse